Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amelia A Cover"'
Autor:
Amelia A Cover, Rahwa Eyasu, Ashley Davis, Omar Harfouch, Emade Ebah, Phyllis Bijole, Catherine Gannon, Grace Garrett, Vivian Wang, Michelle Spikes, F N U Imani, Miriam Jones, Henry Masur, Shyam Kottilil, Sarah Kattakuzhy, Elana S Rosenthal
Publikováno v:
Open Forum Infectious Diseases. 9
Background In the U.S., HIV transmission persists largely through sexual transmission in gender and sexual minorities. Transactional sex (TS) is a known risk factor for HIV transmission, yet risk behaviors and engagement in HIV treatment and other me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d72c3ac75adb748e062c959b7de4233
https://doi.org/10.1093/ofid/ofac492.1683
https://doi.org/10.1093/ofid/ofac492.1683
Autor:
Grace Garrett, Rahwa Eyasu, Amelia A Cover, Ashley Davis, Omar Harfouch, Emade Ebah, Phyllis Bijole, Catherine Gannon, Vivian Wang, Michelle Spikes, F N U Imani, Miriam Jones, Henry Masur, Shyam Kottilil, Sarah Kattakuzhy, Elana S Rosenthal
Publikováno v:
Open Forum Infectious Diseases. 9
Background In the United States, HIV is highly prevalent among transgender individuals, but factors contributing to viremia in this population are poorly understood. We aimed to assess factors associated with HIV viremia among transgender people livi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65fc29da3b3bb9f28244467340d9c433
https://doi.org/10.1093/ofid/ofac492.059
https://doi.org/10.1093/ofid/ofac492.059
Autor:
Kristi C Hill, Sarah M Kattakuzhy, Rachel Silk, Rahwa Eyasu, Onyinyechi Ogbumbadiugha, Emade Ebah, Amelia A Cover, Ashley Davis, Britt Gayle, David Sternberg, Phyllis Bijole, Junfeng Sun, Henry Masur, Shyam Kottilil, Daniel Solomon, Elana S Rosenthal
Publikováno v:
Open forum infectious diseases. 9(10)
Background Individuals with hepatitis C (HCV) represent a population that may benefit from pre-exposure prophylaxis (PrEP), given the overlapping risk factors and transmission networks of HCV and HIV. This analysis assesses the prevalence of PrEP ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be308c340c89f88b471b2926a1456019
https://pubmed.ncbi.nlm.nih.gov/36225745
https://pubmed.ncbi.nlm.nih.gov/36225745
Autor:
D'Agata Mount J; The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Sun J; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Davis A; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA., Cover A; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA., Sun L; Haverford College, Haverford, PA, USA., Gannon C; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Derenoncourt M; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA., Garrett G; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Eyasu R; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA., Ebah E; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA., Bijole P; HIPS, Org, Washington, DC, USA., Greenblatt A; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA., Kattakuzhy S; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA., Rosenthal E; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
Publikováno v:
Addiction (Abingdon, England) [Addiction] 2024 Nov; Vol. 119 (11), pp. 1964-1972. Date of Electronic Publication: 2024 Jul 08.
Autor:
Spaderna M; Department of Psychiatry, University of Maryland School of Medicine, 110 South Paca Street 4(th) Floor, Baltimore, Maryland 21201, United States. Electronic address: mspaderna@som.umaryland.edu., Kattakuzhy S; Department of Psychiatry, University of Maryland School of Medicine, 110 South Paca Street 4(th) Floor, Baltimore, Maryland 21201, United States; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, Maryland 21201, United States; DC Partnership for HIV/AIDS Progress, Clinical Research Program, Washington, District of Columbia, United States., Kang SJ; Genetic Epidemiology Research Branch, Intramural Research Program, National Institute of Mental Health, 35 Convent Drive, MSC 3720, Bldg 35A, Room 2E422A, Bethesda, Maryland 20892, United States., George N; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, Maryland 21201, United States., Bijole P; HIPS, 906 H Street NE, Washington, District of Columbia 20002, United States., Ebah E; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, Maryland 21201, United States; DC Partnership for HIV/AIDS Progress, Clinical Research Program, Washington, District of Columbia, United States., Eyasu R; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, Maryland 21201, United States; DC Partnership for HIV/AIDS Progress, Clinical Research Program, Washington, District of Columbia, United States., Ogbumbadiugha O; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, Maryland 21201, United States; DC Partnership for HIV/AIDS Progress, Clinical Research Program, Washington, District of Columbia, United States., Silk R; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, Maryland 21201, United States; DC Partnership for HIV/AIDS Progress, Clinical Research Program, Washington, District of Columbia, United States., Gannon C; DC Partnership for HIV/AIDS Progress, Clinical Research Program, Washington, District of Columbia, United States; Critical Care Medicine Department, Clinical Center, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, United States., Davis A; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, Maryland 21201, United States; DC Partnership for HIV/AIDS Progress, Clinical Research Program, Washington, District of Columbia, United States., Cover A; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, Maryland 21201, United States; DC Partnership for HIV/AIDS Progress, Clinical Research Program, Washington, District of Columbia, United States., Gayle B; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, Maryland 21201, United States; DC Partnership for HIV/AIDS Progress, Clinical Research Program, Washington, District of Columbia, United States., Narayanan S; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, Maryland 21201, United States., Pao M; Office of the Clinical Director, National Institute of Mental Health, National Institutes of Health, 6001 Executive Boulevard, Room 6200, Bethesda, Maryland 20892, United States., Kottilil S; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, Maryland 21201, United States; DC Partnership for HIV/AIDS Progress, Clinical Research Program, Washington, District of Columbia, United States., Rosenthal E; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, Maryland 21201, United States; DC Partnership for HIV/AIDS Progress, Clinical Research Program, Washington, District of Columbia, United States.
Publikováno v:
The International journal on drug policy [Int J Drug Policy] 2023 Jan; Vol. 111, pp. 103906. Date of Electronic Publication: 2022 Nov 13.
Autor:
Brokus C; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Kattakuzhy S; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Gayle B; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Narayanan S; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Davis A; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Cover A; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Eyasu R; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Ebah E; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Ogbumbadiugha-Weekes O; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Hoffmann J; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Silk R; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Stevens J; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Mount J; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Gannon C; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Nussdorf L; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA., Mathur P; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Bijole P; HIPS, Washington, District of Columbia, USA., Jones M; HIPS, Washington, District of Columbia, USA., Kier R; HIPS, Washington, District of Columbia, USA., Sternberg D; HIPS, Washington, District of Columbia, USA., Greenblatt A; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Department of Family and Community Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA., Weintraub E; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA., Masur H; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Kottilil S; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Rosenthal E; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2021 Dec 29; Vol. 9 (3), pp. ofab658. Date of Electronic Publication: 2021 Dec 29 (Print Publication: 2022).